home / stock / vrdn / vrdn quote
Last: | $12.16 |
---|---|
Change Percent: | 1.29% |
Open: | $13.04 |
Close: | $12.16 |
High: | $13.05 |
Low: | $12.14 |
Volume: | 532,757 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$12.16 | $13.04 | $12.16 | $13.05 | $12.14 | 532,757 | 07-02-2024 |
$13.21 | $12.98 | $13.21 | $13.365 | $12.9 | 654,229 | 07-01-2024 |
$13.01 | $12.79 | $13.01 | $13.08 | $12.53 | 2,969,436 | 06-28-2024 |
$12.78 | $12.31 | $12.78 | $12.9 | $12.105 | 701,481 | 06-27-2024 |
$12.31 | $12.72 | $12.31 | $12.72 | $12.01 | 799,208 | 06-26-2024 |
$12.76 | $13.15 | $12.76 | $13.16 | $12.76 | 568,065 | 06-25-2024 |
$13.21 | $12.7 | $13.21 | $13.31 | $12.49 | 998,782 | 06-24-2024 |
$12.57 | $12.4 | $12.57 | $12.89 | $12.135 | 3,790,384 | 06-21-2024 |
$12.38 | $12.21 | $12.38 | $12.45 | $11.79 | 1,834,312 | 06-20-2024 |
$12.18 | $12.11 | $12.18 | $12.23 | $11.7 | 1,144,678 | 06-19-2024 |
$12.18 | $12.11 | $12.18 | $12.23 | $11.7 | 1,144,678 | 06-18-2024 |
$12.2 | $12.33 | $12.2 | $12.46 | $11.94 | 1,183,820 | 06-17-2024 |
$12.44 | $12.94 | $12.44 | $13.01 | $12.15 | 829,966 | 06-14-2024 |
$13.15 | $12.62 | $13.15 | $13.16 | $12.5 | 755,237 | 06-13-2024 |
$12.66 | $14.02 | $12.66 | $14.17 | $12.515 | 1,079,467 | 06-12-2024 |
$13.46 | $12.46 | $13.46 | $13.54 | $11.92 | 1,803,596 | 06-11-2024 |
$12.22 | $11.85 | $12.22 | $12.24 | $11.74 | 1,019,425 | 06-10-2024 |
$12.17 | $12 | $12.17 | $12.271 | $11.83 | 874,925 | 06-07-2024 |
$12.23 | $13.02 | $12.23 | $13.02 | $12.21 | 747,473 | 06-06-2024 |
$12.34 | $11.73 | $12.34 | $12.5 | $11.43 | 1,090,277 | 06-05-2024 |
News, Short Squeeze, Breakout and More Instantly...
Viridian Therapeutics Inc Com Company Name:
VRDN Stock Symbol:
NASDAQ Market:
Viridian Therapeutics Inc Com Website:
2024-06-11 15:00:09 ET Gregory Renza from RBC Capital issued a price target of $35.00 for VRDN on 2024-06-11 12:47:00. The adjusted price target was set to $35.00. At the time of the announcement, VRDN was trading at $12.9625. The overall price target consensus is at $35...
2024-06-11 14:30:05 ET RBC Capital analyst issues OUTPERFORM recommendation for VRDN on June 11, 2024 12:47PM ET. The previous analyst recommendation was Outperform. VRDN was trading at $12.9625 at issue of the analyst recommendation. The overall analyst consensus : BUY....
- On track to initiate two phase 3 clinical trials of VRDN-003 in August 2024 - - REVEAL-1 and REVEAL-2, will evaluate two active dosing regimens of subcutaneously (SC) administered VRDN-003 in active and chronic thyroid eye disease (TED), with topline readout anticipated in the first hal...